Rick E Winningham
2011 - Innoviva
In 2011, Rick E Winningham earned a total compensation of $6.8M as Chief Executive Officer at Innoviva, a 251% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $586,521 |
|---|---|
| Salary | $812,796 |
| Stock Awards | $5,440,600 |
| Other | $1,025 |
| Total | $6,840,942 |
Winningham received $5.4M in stock awards, accounting for 80% of the total pay in 2011.
Winningham also received $586.5K in non-equity incentive plan, $812.8K in salary and $1K in other compensation.
Rankings
In 2011, Rick E Winningham's compensation ranked 686th out of 10,747 executives tracked by ExecPay. In other words, Winningham earned more than 93.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 686 out of 10,747 | 94th |
Division Manufacturing | 248 out of 3,958 | 94th |
Major group Chemicals And Allied Products | 58 out of 1,031 | 94th |
Industry group Drugs | 29 out of 779 | 96th |
Industry Pharmaceutical Preparations | 24 out of 567 | 96th |
Source: SEC filing on April 15, 2014.
Winningham's colleagues
We found four more compensation records of executives who worked with Rick E Winningham at Innoviva in 2011.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019